United States: Accord BioPharma, Inc. Announces FDA Approval Of HERCESSI (Trastuzumab-strf) - Goodwin Procter LLP
Wednesday, 8 May 2024 ()
On April 29, 2024, Accord BioPharma, Inc. announced that the U.S. Food and Drug Administration (FDA) approved HERCESSI (trastuzumab-strf).
|
||||
You Might Like |
||||
